UnitedHealth Group reported bottom-line earnings that surpassed estimates despite regulatory challenges impacting revenue.
This was the stock's second consecutive day of gains.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
B, consensus $445.64B. The company said, “UnitedHealth Group affirmed the 2025 performance outlook established in December 2024, including reve ...
The stock's fall snapped a four-day winning streak.
JPMorgan posts record profits, Lululemon raises guidance, Cogeco kickstarts three-year plan, and UnitedHealth beats ...
The stock market rebounded to or above key levels on tame inflation data and strong bank earnings. Many stocks flashed buy ...
UnitedHealth Group (NYSE:UNH), a leading diversified healthcare company with a substantial market capitalization of $469.7 ...